Cost-effectiveness analysis of 30-month vs 12-month dual antiplatelet therapy with clopidogrel and aspirin after drug-eluting stents in patients with acute coronary syndrome. [electronic resource]
Producer: 20180702Description: 789-796 p. digitalISSN:- 1932-8737
- Acute Coronary Syndrome -- diagnosis
- Aspirin -- administration & dosage
- Clopidogrel
- Computer Simulation
- Coronary Thrombosis -- economics
- Cost-Benefit Analysis
- Decision Trees
- Disease-Free Survival
- Drug Administration Schedule
- Drug Costs
- Drug Therapy, Combination
- Drug-Eluting Stents -- economics
- Hemorrhage -- chemically induced
- Humans
- Middle Aged
- Models, Economic
- Monte Carlo Method
- Myocardial Infarction -- economics
- Odds Ratio
- Percutaneous Coronary Intervention -- adverse effects
- Platelet Aggregation Inhibitors -- administration & dosage
- Quality-Adjusted Life Years
- Risk Factors
- Stroke -- economics
- Ticlopidine -- administration & dosage
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.